Yi‐Gang Wan

1.3k total citations
65 papers, 999 citations indexed

About

Yi‐Gang Wan is a scholar working on Nephrology, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Yi‐Gang Wan has authored 65 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Nephrology, 20 papers in Complementary and alternative medicine and 19 papers in Molecular Biology. Recurrent topics in Yi‐Gang Wan's work include Chronic Kidney Disease and Diabetes (17 papers), Renal Diseases and Glomerulopathies (16 papers) and Natural Compounds in Disease Treatment (10 papers). Yi‐Gang Wan is often cited by papers focused on Chronic Kidney Disease and Diabetes (17 papers), Renal Diseases and Glomerulopathies (16 papers) and Natural Compounds in Disease Treatment (10 papers). Yi‐Gang Wan collaborates with scholars based in China, Japan and Malaysia. Yi‐Gang Wan's co-authors include Yue Tu, Zi-Yue Wan, Yinglu Liu, Haitao Tang, Renmao Tang, Bu-Hui Liu, Wei Wu, Qi‐Jun Fang, Wei Wu and Wei Sun and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and British Journal of Pharmacology.

In The Last Decade

Yi‐Gang Wan

63 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Gang Wan China 18 472 332 186 107 96 65 999
Yunman Wang China 20 421 0.9× 365 1.1× 114 0.6× 158 1.5× 72 0.8× 36 1.1k
Xiangming Qi China 21 416 0.9× 313 0.9× 160 0.9× 127 1.2× 208 2.2× 50 1.1k
Yueyi Deng China 15 315 0.7× 443 1.3× 181 1.0× 107 1.0× 57 0.6× 39 1.1k
Yanbin Gao China 16 446 0.9× 197 0.6× 61 0.3× 94 0.9× 48 0.5× 29 788
Xue‐qi Liu China 21 657 1.4× 330 1.0× 44 0.2× 146 1.4× 123 1.3× 33 1.2k
Lianbo Wei China 15 340 0.7× 112 0.3× 93 0.5× 121 1.1× 60 0.6× 33 731
Zhilei Wang China 19 654 1.4× 171 0.5× 77 0.4× 186 1.7× 179 1.9× 43 1.1k
Lucas Opazo-Ríos Spain 12 347 0.7× 291 0.9× 44 0.2× 155 1.4× 169 1.8× 20 1.0k
Jibo Han China 23 869 1.8× 160 0.5× 89 0.5× 191 1.8× 286 3.0× 63 1.5k
Yong Su China 15 365 0.8× 104 0.3× 93 0.5× 91 0.9× 42 0.4× 36 665

Countries citing papers authored by Yi‐Gang Wan

Since Specialization
Citations

This map shows the geographic impact of Yi‐Gang Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Gang Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Gang Wan more than expected).

Fields of papers citing papers by Yi‐Gang Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Gang Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Gang Wan. The network helps show where Yi‐Gang Wan may publish in the future.

Co-authorship network of co-authors of Yi‐Gang Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Gang Wan. A scholar is included among the top collaborators of Yi‐Gang Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Gang Wan. Yi‐Gang Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Yan, Wei Wu, Yi‐Gang Wan, et al.. (2023). [Effect and mechanism of Dahuang Zhechong Pills in improving liver aging in rats by regulating ROS-mediated PI3K/Akt/FoxO4 signaling pathway].. PubMed. 48(11). 3014–3021. 2 indexed citations
3.
4.
Wang, Wenwen, Yinglu Liu, Meizi Wang, et al.. (2021). Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy. Frontiers in Pharmacology. 12. 662706–662706. 28 indexed citations
5.
Liu, Bu-Hui, Yinglu Liu, Haiming Yang, et al.. (2021). Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis. Frontiers in Pharmacology. 11. 586725–586725. 14 indexed citations
6.
Fang, Qi‐Jun, Jianjing Liu, Yi‐Gang Wan, et al.. (2020). [Exploring molecular mechanisms of fucoidan in improving human proximal renal tubular epithelial cells aging by targeting autophagy signaling pathways].. PubMed. 45(24). 6003–6011. 4 indexed citations
7.
8.
Wu, Wei, Bu-Hui Liu, Yi‐Gang Wan, et al.. (2019). [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].. PubMed. 44(24). 5457–5464. 10 indexed citations
9.
Liu, Yinglu, Ge Shi, Dongwei Cao, et al.. (2018). [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].. PubMed. 43(21). 4192–4197. 2 indexed citations
10.
11.
Tu, Yue, Liubao Gu, Wei Wu, et al.. (2017). Rhein Inhibits Autophagy in Rat Renal Tubular Cells by Regulation of AMPK/mTOR Signaling. Scientific Reports. 7(1). 43790–43790. 69 indexed citations
12.
Wu, Wei, Jingjing Yang, Haiming Yang, et al.. (2017). Multi-glycoside of Tripterygium wilfordii Hook. f. attenuates glomerulosclerosis in a rat model of diabetic nephropathy by exerting anti-microinflammatory effects without affecting hyperglycemia. International Journal of Molecular Medicine. 40(3). 721–730. 35 indexed citations
13.
Wu, Wei, Jingjing Yang, Yi‐Gang Wan, et al.. (2017). [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].. PubMed. 42(1). 49–55. 7 indexed citations
14.
Wu, Wei, Yanru Huang, Yi‐Gang Wan, et al.. (2016). Effects and mechanisms of UCG ameliorating renal interstitial fibrosis by regulating TGF-β1/SnoN/Smads signaling pathway in renal failure rats. China Journal of Chinese Materia Medica. 41(12). 2291–2297. 5 indexed citations
15.
16.
Gao, Kun, Yuan Chi, Kai Li, et al.. (2012). NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury. Free Radical Biology and Medicine. 53(6). 1286–1297. 31 indexed citations
17.
Yao, Jian, Tao Huang, Xin Fang, et al.. (2010). Disruption of gap junctions attenuates aminoglycoside‐elicited renal tubular cell injury. British Journal of Pharmacology. 160(8). 2055–2068. 22 indexed citations
18.
Wan, Yi‐Gang, Wei Sun, Huilan Zhang, et al.. (2009). Multi-Glycoside of <i>Tripterygium wilfordii </i>Hook f. Ameliorates Prolonged Mesangial Lesions in Experimental Progressive Glomerulonephritis. Nephron Experimental Nephrology. 114(1). e7–e14. 19 indexed citations
19.
Wan, Yi‐Gang, et al.. (2005). [Suppressive effects of GTW treatment on mesangial lesions in experimental irreversible glomerulosclerosis].. PubMed. 30(5). 361–5. 2 indexed citations
20.
Gu, Liubao, et al.. (2003). [Advances in the study on molecular mechanism of diabetic nephropathy treated with Rheum officinale].. PubMed. 28(8). 703–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunman Wang Breakdown of academic impact, for papers by Xiangming Qi Breakdown of academic impact, for papers by Yueyi Deng Breakdown of academic impact, for papers by Yanbin Gao Breakdown of academic impact, for papers by Xue‐qi Liu Breakdown of academic impact, for papers by Lianbo Wei Breakdown of academic impact, for papers by Zhilei Wang Breakdown of academic impact, for papers by Lucas Opazo-Ríos Breakdown of academic impact, for papers by Jibo Han Breakdown of academic impact, for papers by Yong Su
Rankless by CCL
2026